BRIEF-Bluebird Bio Initiates Restructuring Intended To Optimize Cost Structure And Enable Quarterly Cash Flow Break-Even In The 2H25

Reuters

Sep 24, 2024

Sept 24 (Reuters) - bluebird bio Inc :

* BLUEBIRD BIO INITIATES RESTRUCTURING INTENDED TO OPTIMIZE COST STRUCTURE AND ENABLE QUARTERLY CASH FLOW BREAK-EVEN IN THE SECOND HALF OF 2025

* BLUEBIRD BIO INC - ACTIONS INTENDED TO REDUCE CASH OPERATING EXPENSES BY APPROXIMATELY 20%

* BLUEBIRD BIO INC - RESTRUCTURING TO REDUCE CASH OPERATING EXPENSES BY 20%

* BLUEBIRD BIO INC - 20% REDUCTION IN CASH OPERATING EXPENSES EXPECTED BY Q3 2025

* BLUEBIRD BIO INC - WORKFORCE REDUCTION OF APPROXIMATELY 25%

* BLUEBIRD BIO INC - TO FOCUS ON COMMERCIAL LAUNCHES OF LYFGENIA, ZYNTEGLO, AND SKYSONA

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2469469050"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2469469050\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2469469050?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-24 19:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2469469050","market":"us","top_or_hot":-1,"title":"BRIEF-Bluebird Bio Initiates Restructuring Intended To Optimize Cost Structure And Enable Quarterly Cash Flow Break-Even In The 2H25","media":"Reuters","content":"<html><body><p>Sept 24 (Reuters) - bluebird bio Inc   :</p><p>   * BLUEBIRD BIO INITIATES RESTRUCTURING INTENDED TO OPTIMIZE COST STRUCTURE AND ENABLE QUARTERLY CASH FLOW BREAK-EVEN IN THE SECOND HALF OF 2025</p><p>   * BLUEBIRD BIO INC - ACTIONS INTENDED TO REDUCE CASH OPERATING EXPENSES BY APPROXIMATELY 20%</p><p>   * BLUEBIRD BIO INC - RESTRUCTURING TO REDUCE CASH OPERATING EXPENSES BY 20%</p><p>   * BLUEBIRD BIO INC - 20% REDUCTION IN CASH OPERATING EXPENSES EXPECTED BY Q3 2025</p><p>   * BLUEBIRD BIO INC - WORKFORCE REDUCTION OF APPROXIMATELY 25%</p><p>   * BLUEBIRD BIO INC - TO FOCUS ON COMMERCIAL LAUNCHES OF LYFGENIA, ZYNTEGLO, AND SKYSONA</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Bluebird Bio Initiates Restructuring Intended To Optimize Cost Structure And Enable Quarterly Cash Flow Break-Even In The 2H25</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Bluebird Bio Initiates Restructuring Intended To Optimize Cost Structure And Enable Quarterly Cash Flow Break-Even In The 2H25\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2024-09-24 19:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Sept 24 (Reuters) - bluebird bio Inc   :</p><p>   * BLUEBIRD BIO INITIATES RESTRUCTURING INTENDED TO OPTIMIZE COST STRUCTURE AND ENABLE QUARTERLY CASH FLOW BREAK-EVEN IN THE SECOND HALF OF 2025</p><p>   * BLUEBIRD BIO INC - ACTIONS INTENDED TO REDUCE CASH OPERATING EXPENSES BY APPROXIMATELY 20%</p><p>   * BLUEBIRD BIO INC - RESTRUCTURING TO REDUCE CASH OPERATING EXPENSES BY 20%</p><p>   * BLUEBIRD BIO INC - 20% REDUCTION IN CASH OPERATING EXPENSES EXPECTED BY Q3 2025</p><p>   * BLUEBIRD BIO INC - WORKFORCE REDUCTION OF APPROXIMATELY 25%</p><p>   * BLUEBIRD BIO INC - TO FOCUS ON COMMERCIAL LAUNCHES OF LYFGENIA, ZYNTEGLO, AND SKYSONA</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2469469050","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2469469050","pubTimestamp":1727175753,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Sept 24  - bluebird bio Inc   :   * BLUEBIRD BIO INITIATES RESTRUCTURING INTENDED TO OPTIMIZE COST STRUCTURE AND ENABLE QUARTERLY CASH FLOW BREAK-EVEN IN THE SECOND HALF OF 2025   * BLUEBIRD BIO INC - ACTIONS INTENDED TO REDUCE CASH OPERATING EXPENSES BY APPROXIMATELY 20%   * BLUEBIRD BIO INC - RESTRUCTURING TO REDUCE CASH OPERATING EXPENSES BY 20%   * BLUEBIRD BIO INC - 20% REDUCTION IN CASH OPERATING EXPENSES EXPECTED BY Q3 2025   * BLUEBIRD BIO INC - WORKFORCE REDUCTION OF APPROXIMATELY 25%   * BLUEBIRD BIO INC - TO FOCUS ON COMMERCIAL LAUNCHES OF LYFGENIA, ZYNTEGLO, AND SKYSONASource text for Eikon:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BK4578":"CAR-T","BK4556":"基因编辑"},"translate_title":"简介-蓝鸟生物启动重组，旨在优化成本结构并在25年下半年实现季度现金流收支平衡","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BLUE":0.9},"content_text":"Sept 24 (Reuters) - bluebird bio Inc   :   * BLUEBIRD BIO INITIATES RESTRUCTURING INTENDED TO OPTIMIZE COST STRUCTURE AND ENABLE QUARTERLY CASH FLOW BREAK-EVEN IN THE SECOND HALF OF 2025   * BLUEBIRD BIO INC - ACTIONS INTENDED TO REDUCE CASH OPERATING EXPENSES BY APPROXIMATELY 20%   * BLUEBIRD BIO INC - RESTRUCTURING TO REDUCE CASH OPERATING EXPENSES BY 20%   * BLUEBIRD BIO INC - 20% REDUCTION IN CASH OPERATING EXPENSES EXPECTED BY Q3 2025   * BLUEBIRD BIO INC - WORKFORCE REDUCTION OF APPROXIMATELY 25%   * BLUEBIRD BIO INC - TO FOCUS ON COMMERCIAL LAUNCHES OF LYFGENIA, ZYNTEGLO, AND SKYSONASource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}